Together, these data suggest that modifying S2-P by replacing an acidic amino acid in the vicinity of Tyr 51 enhanced the interaction with pro-MMP-7 and thereby inhibited MMP-7 activity and the cancer activities of colon cancer cells. Here, MMP7 is linked to colonic neoplasm.